Bionik Laboratories Corp (BNKL):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Bionik Laboratories Corp (BNKL) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7887)・商品コード:DATA904C7887
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:54
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body exoskeleton for wheelchair bound individuals suffering from spinal cord injuries, strokes, and other mobility disabilities and supports them to restore gait and walk again during the rehabilitation process. Bionik provides rehabilitation solutions to individuals with neurological disorders. The company offers partnerships with other companies and universities in related industries. It sells products across Canada. Bionik is headquartered in Toronto, Ontario, Canada.

Bionik Laboratories Corp (BNKL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bionik Laboratories Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bionik Laboratories Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bionik Laboratories Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bionik Laboratories Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Bionik Laboratories Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bionik Laboratories Corp, Medical Equipment, Deal Details 11
Partnerships 11
Bionik Labs Enters into Option Agreement with University of Texas at Dallas 11
Bionik Labs Enters into Distribution Agreement with Curexo 12
Bionik Labs Enters into Co-Development Agreement with Wistron 13
Bionik Labs Forms Joint Venture with Ginger Capital Investment Holding 14
Equity Offering 15
Bionik Labs Raises USD1 Million in Private Placement of Shares upon Exercise of Warrants 15
Bionik Labs Files Registration Statement for Public Offering of Units for up to USD12 Million 16
Bionik Labs Raises USD1.6 Million in Sixth Tranche Private Placement of Units 17
Bionik Labs Raises USD1.1 Million in Fifth Tranche Private Placement of Units 19
Bionik Labs Raises USD2.5 Million in Fourth Tranche Private Placement of Units 20
Bionik Labs Raises USD0.7 Million in Third Tranche Private Placement of Units 21
Bionik Labs Raises USD1 Million in Second Tranche Private Placement of Units 22
Bionik Labs Raises USD6 Million in First Tranche Private Placement of Units 23
Bionik Labs Raises USD5.7 Million in Private Placement of Units 24
Bionik Labs Raises USD2.6 Million in Private Placement of Shares 25
Acquisition 26
Bionik Labs Acquires Interactive Motion Technologies 26
Bionik Laboratories Corp – Key Competitors 27
Bionik Laboratories Corp – Key Employees 28
Bionik Laboratories Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 14, 2018: Bionik Laboratories reports first quarter fiscal 2019 financial results 30
Jun 27, 2018: Bionik Laboratories Reports Fiscal Year 2018 Financial Results 32
Feb 13, 2018: Bionik Laboratories Reports Third Quarter Fiscal Year 2018 Financial Results 34
Nov 14, 2017: Bionik Laboratories Reports Second Quarter Fiscal Year 2018 Financial Results 35
Aug 15, 2017: Bionik Laboratories Reports First Quarter Fiscal Year 2018 Financial Results 36
Jun 30, 2017: Bionik Laboratories Reports Fiscal Year Ended 2017 Financial Results 37
Feb 15, 2017: Bionik Laboratories Reports Third Quarter Fiscal Year 2017 Financial Results 38
Corporate Communications 40
Sep 13, 2018: Bionik Laboratories appoints Dr. Audrey D. Thevenon and Charles Matine to its Board of Directors 40
Jun 11, 2018: Bionik Laboratories Names Renaud Maloberti As Chief Commercial Officer 41
Mar 20, 2018: Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors 42
Jan 29, 2018: Bionik Laboratories Appoints Andre Auberton-Herve as Chairman of Board of Directors 43
Sep 07, 2017: Bionik Laboratories Appoints Dr. Eric Dusseux as Chief Executive Officer 44
Jul 27, 2017: Bionik Laboratories Names Dr. Eric Dusseux to its Board of Directors 45
Mar 14, 2017: Bionik Laboratories Announces Key Hires to Commercialization Team 46
Mar 07, 2017: Bionik Laboratories Hires Bill Harris to Serve as Marketing Director 47
Feb 27, 2017: Bionik Laboratories Appoints Malcolm G. Bock as Vice President of Engineering 48
Product News 49
Mar 29, 2017: Bionik Laboratories to Attend the 2017 American Occupational Therapy Association (AOTA) Conference and Centennial Celebration 49
Other Significant Developments 50
Aug 22, 2017: Bionik Laboratories Issues Letter to Shareholders 50
Apr 25, 2017: Bionik Laboratories Reaches Milestone with Shipment of 250th Interactive Robotic Therapy System for Patient Rehabilitation 52
Mar 09, 2017: Bionik Laboratories Provides Company Highlights 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Bionik Laboratories Corp, Medical Equipment, Key Facts, 2018 2
Bionik Laboratories Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bionik Laboratories Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bionik Laboratories Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Bionik Laboratories Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bionik Laboratories Corp, Deals By Market, 2012 to YTD 2018 9
Bionik Laboratories Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Bionik Labs Enters into Option Agreement with University of Texas at Dallas 11
Bionik Labs Enters into Distribution Agreement with Curexo 12
Bionik Labs Enters into Co-Development Agreement with Wistron 13
Bionik Labs Forms Joint Venture with Ginger Capital Investment Holding 14
Bionik Labs Raises USD1 Million in Private Placement of Shares upon Exercise of Warrants 15
Bionik Labs Files Registration Statement for Public Offering of Units for up to USD12 Million 16
Bionik Labs Raises USD1.6 Million in Sixth Tranche Private Placement of Units 17
Bionik Labs Raises USD1.1 Million in Fifth Tranche Private Placement of Units 19
Bionik Labs Raises USD2.5 Million in Fourth Tranche Private Placement of Units 20
Bionik Labs Raises USD0.7 Million in Third Tranche Private Placement of Units 21
Bionik Labs Raises USD1 Million in Second Tranche Private Placement of Units 22
Bionik Labs Raises USD6 Million in First Tranche Private Placement of Units 23
Bionik Labs Raises USD5.7 Million in Private Placement of Units 24
Bionik Labs Raises USD2.6 Million in Private Placement of Shares 25
Bionik Labs Acquires Interactive Motion Technologies 26
Bionik Laboratories Corp, Key Competitors 27
Bionik Laboratories Corp, Key Employees 28
Bionik Laboratories Corp, Other Locations 29
Bionik Laboratories Corp, Subsidiaries 29

List of Figures
Bionik Laboratories Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bionik Laboratories Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bionik Laboratories Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bionik Laboratories Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bionik Laboratories Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Bionik Laboratories Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Bionik Laboratories Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Bionik Laboratories Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★調査レポート[Bionik Laboratories Corp (BNKL):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C7887)販売に関する免責事項を必ずご確認ください。
★調査レポート[Bionik Laboratories Corp (BNKL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆